**Core Concept**
N-MYC amplification is a genetic alteration involving the MYCN gene, leading to its overexpression. This phenomenon is closely associated with specific types of cancers that exhibit rapid cell growth and proliferation. In the context of neuroblastoma, N-MYC amplification is a critical prognostic factor, often indicating a more aggressive disease course.

**Why the Correct Answer is Right**
N-MYC amplification is a hallmark of neuroblastoma, a type of pediatric cancer originating from the sympathetic nervous system. The MYCN gene, located on chromosome 2p24, encodes a transcription factor that regulates cell growth and differentiation. Amplification of MYCN leads to increased expression of the protein, driving unchecked cell proliferation and tumor progression in neuroblastoma. In contrast, other cancers like Burkitt lymphoma, squamous cell carcinoma of the lung, and astrocytoma are not characteristically associated with N-MYC amplification.

**Why Each Wrong Option is Incorrect**
**Option A:** Burkitt lymphoma is characterized by the translocation of the MYC gene on chromosome 8q24, not N-MYC amplification. This genetic alteration leads to the overexpression of MYC, driving the aggressive growth of Burkitt lymphoma cells.
**Option B:** Squamous cell carcinoma of the lung is associated with various genetic alterations, including mutations in the TP53 gene, but not N-MYC amplification. Other genetic and epigenetic changes contribute to the development and progression of this cancer.
**Option C:** Astrocytoma, a type of brain tumor, exhibits a range of genetic alterations, including mutations in the TP53 and IDH1 genes. However, N-MYC amplification is not a characteristic feature of astrocytoma.

**Clinical Pearl / High-Yield Fact**
When diagnosing neuroblastoma, clinicians should be aware of the prognostic significance of N-MYC amplification, as it often correlates with a more aggressive disease course and poorer outcomes. This knowledge can inform treatment decisions and guide further diagnostic and therapeutic approaches.

**✓ Correct Answer: D. Neuroblastoma**